AUROBINDO PHARMA LTD FDA Approval ANDA 213875

ANDA 213875

AUROBINDO PHARMA LTD

FDA Drug Application

Application #213875

Application Sponsors

ANDA 213875AUROBINDO PHARMA LTD

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL25MG0DICLOFENAC POTASSIUMDICLOFENAC POTASSIUM

FDA Submissions

UNKNOWN; ORIG1AP2021-10-19STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213875
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"DICLOFENAC POTASSIUM","activeIngredients":"DICLOFENAC POTASSIUM","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/19\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-19
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.